|1.||Yue, Hui: 4 articles (08/2005 - 02/2003)|
|2.||Matsuura, N: 3 articles (10/2001 - 01/2001)|
|3.||Huang, Tim H-M: 2 articles (01/2014 - 06/2011)|
|4.||Joseph, B: 2 articles (01/2012 - 11/2009)|
|5.||Vlachos, P: 2 articles (01/2012 - 11/2009)|
|6.||Fukunaga, Masaharu: 2 articles (08/2004 - 12/2002)|
|7.||Feng, Xin-Li: 2 articles (07/2003 - 02/2003)|
|8.||Ma, Shu-Ren: 2 articles (07/2003 - 02/2003)|
|9.||Song, Fu-Lin: 2 articles (07/2003 - 02/2003)|
|10.||Tsujimoto, M: 2 articles (10/2001 - 01/2001)|
12/01/2002 - "In this study, 10 diploid voluntary artificial abortions (ABs), 20 diploid HAs, 20 triploid PMs, and 44 diploid CMs (including 4 persistent diseases), all of which were in the first trimester, were evaluated by immunohistochemistry of formalin-fixed tissues using a monoclonal antibody against p57(KIP2) protein (p57), a putative paternally imprinted inhibitor gene. "
|2.||Type 2 Diabetes Mellitus (MODY)
|3.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/15/2015 - "In silico, the C allele of LSP1-rs3817198 was predicted to increase expression of the tumor suppressor cyclin-dependent kinase inhibitor 1C (CDKN1C). "
01/01/2012 - "The positive expression rates of p57KIP2 protein in the invasive breast cancers and surrounding normal tissue were 30.3% (27/89) and 65% (13/20), respectively. "
01/01/2012 - "The cell cycle gene cyclin-dependent kinase inhibitor 1C was correlated with the maximum tracer uptake (SUVmax) in the tumors. "
01/01/2012 - "p57 (Kip2, cyclin-dependent kinase inhibitor 1C), often found downregulated in cancer, is reported to hold tumor suppressor properties. "
10/01/2011 - "Finally, accumulating evidence indicates that p57(Kip2) protein is frequently downregulated in different types of human epithelial and nonepithelial cancers as a consequence of genetic and epigenetic events. "
|5.||Neoplasm Metastasis (Metastasis)
08/01/2011 - "Cyclin-dependent kinase inhibitor 1C CDKN1C (p57(KIP2)) regulates several hallmarks of cancer, including apoptosis, cell invasion and metastasis, tumor differentiation and angiogenesis. "
08/28/2005 - "p57(kip2) protein positive expression remarkably correlated with tumor cell differentiation (P<0.05), but not with lymph node metastasis (P>0.05). "
06/01/2003 - "The p57(kip2) protein positive-expression correlated significantly with tumor cell differentiation (P < 0.05) and did not correlate significantly with lymph node metastasis (P > 0.05). "
07/01/2003 - "The positive-expression rate of p57(kip2) protein in tumor tissue of pancreatic cancer was 46.9%, which was lower than that in adjacent pancreatic tissue (75.0%) (Chi(2)=5.317, P< 0.05); p57(kip2) protein positive-expression was remarkably correlated with tumor cell differentiation (P< 0.05), but was not correlated with lymph node metastasis (P >0.05). "
02/28/2005 - "The reduced expression of p57(kip2) protein correlated significantly with moderate or low differentiation of tumor cells (P = 0.007 <0.05), high clinical stage (P = 0.041 <0.05) and poor prognosis (P = 0.036 <0.05), but did not correlate significantly with metastasis, tumor size, level of AFP and age (P>0.05). "
|1.||Cyclin-Dependent Kinase 4
|3.||Messenger RNA (mRNA)
|5.||Proliferating Cell Nuclear Antigen (PCNA)
|6.||Proteins (Proteins, Gene)
|7.||Cyclin-Dependent Kinase 2
|8.||Small Interfering RNA (siRNA)
|9.||Telomerase (Telomerase Reverse Transcriptase)